GA²LEN, the Global Allergy and Asthma Excellence Network was created in 2005 to combat fragmentation in the European research area, ensuring excellence in EU allergy and asthma research by bringing together institutions and researchers from across the EU. The network notably put in place centralized structures and a central office overseeing the multiple assets in knowledge in the different GA²LEN partners, enabling them to optimally synchronize their research efforts.
GA²LEN is now recognized worldwide as the EU’s groundbreaking allergy organization.
GA²LEN’s vision is further reduce the burden of allergic diseases globally by improving the health of citizens with allergic diseases; increasing the competitiveness and boosting the innovative capacity of health-related industries and businesses while addressing health issues including emerging allergies.
Research
Accelerate the application of research results into clinical practice development
Training
Promote training and greater integration between public and academic sectors
Healthcare
Significantly contribute to developing better health care and improving the quality of life for allergy and asthma patients